156 related articles for article (PubMed ID: 35763636)
1. Development, Characterization, and In Vitro Evaluation of Cytotoxic Activity of Rutin Loaded PCL-PEG Nanoparticles Against Skov3 Ovarian Cancer Cell.
Firouzai-Amandi A; Tarahomi M; Rahmani Youshanlouie H; Mosaddeghi Heris R; Jafari-Gharabaghlou D; Zarghami N; Dadashpour M
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1951-1957. PubMed ID: 35763636
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells.
Faramarzi L; Dadashpour M; Sadeghzadeh H; Mahdavi M; Zarghami N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):737-746. PubMed ID: 30892093
[TBL] [Abstract][Full Text] [Related]
3. Preparation of rutin-loaded mesoporous silica nanoparticles and evaluation of its physicochemical, anticancer, and antibacterial properties.
Memar MY; Dalir Abdolahinia E; Yekani M; Kouhsoltani M; Sharifi S; Maleki Dizaj S
Mol Biol Rep; 2023 Jan; 50(1):203-213. PubMed ID: 36319783
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application.
Jafari-Gharabaghlou D; Dadashpour M; Khanghah OJ; Salmani-Javan E; Zarghami N
Mol Biol Rep; 2023 Apr; 50(4):3023-3033. PubMed ID: 36662452
[TBL] [Abstract][Full Text] [Related]
5. Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells.
Jalilzadeh N; Samadi N; Salehi R; Dehghan G; Iranshahi M; Dadpour MR; Hamishehkar H
Sci Rep; 2020 Jan; 10(1):1606. PubMed ID: 32005894
[TBL] [Abstract][Full Text] [Related]
6. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975
[TBL] [Abstract][Full Text] [Related]
7. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Characterization of Chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line.
Eatemadi A; Daraee H; Aiyelabegan HT; Negahdari B; Rajeian B; Zarghami N
Biomed Pharmacother; 2016 Dec; 84():1915-1922. PubMed ID: 27847208
[TBL] [Abstract][Full Text] [Related]
9. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and in vitro and in vivo delivery of sulforaphane by PCL-PEG-PCL copolymeric-based micelles.
Kheiri Manjili H; Sharafi A; Attari E; Danafar H
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1728-1739. PubMed ID: 28147711
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.
Danafar H; Sharafi A; Kheiri Manjili H; Andalib S
Pharm Dev Technol; 2017 Aug; 22(5):642-651. PubMed ID: 26916923
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
Gao X; Wang B; Wei X; Men K; Zheng F; Zhou Y; Zheng Y; Gou M; Huang M; Guo G; Huang N; Qian Z; Wei Y
Nanoscale; 2012 Nov; 4(22):7021-30. PubMed ID: 23044718
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vivo evaluation of anti-plasmodial properties of artemisinin-loaded PCL-PEG-PCL nanoparticles.
Ramazani A; Keramati M; Malvandi H; Danafar H; Kheiri Manjili H
Pharm Dev Technol; 2018 Nov; 23(9):911-920. PubMed ID: 28851256
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and in vitro evaluation of magnetic nanoparticles modified with PCL-PEG-PCL for controlled delivery of 5FU.
Asadi N; Annabi N; Mostafavi E; Anzabi M; Khalilov R; Saghfi S; Mehrizadeh M; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):938-945. PubMed ID: 29468888
[TBL] [Abstract][Full Text] [Related]
16. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.
Cho H; Lai TC; Kwon GS
J Control Release; 2013 Feb; 166(1):1-9. PubMed ID: 23246471
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Dual Bioactive Compounds Artemisinin and Metformin Co-loaded in PLGA-PEG Nano-particles on Breast Cancer Cell lines: Potential Apoptotic and Anti-proliferative Action.
Hassani N; Jafari-Gharabaghlou D; Dadashpour M; Zarghami N
Appl Biochem Biotechnol; 2022 Oct; 194(10):4930-4945. PubMed ID: 35674922
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Characterization and Evaluation of the Cytotoxicity Effects of Nisin and Nisin-Loaded PLA-PEG-PLA Nanoparticles on Gastrointestinal (AGS and KYSE-30), Hepatic (HepG2) and Blood (K562) Cancer Cell Lines.
Goudarzi F; Asadi A; Afsharpour M; Jamadi RH
AAPS PharmSciTech; 2018 May; 19(4):1554-1566. PubMed ID: 29470827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
